ACR appropriateness criteria ® Local-regional Recurrence (LR) and salvage surgery breast cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 2, 2012, Pages 178-182

  Halyard, Michele Y ^a,k   Wasif, Nabil ^a   Harris, Eleanor E R ^b   Arthur, Douglas W ^c   Bailey, Lisa ^d   Bellon, Jennifer R ^f   Carey, Lisa ^h   Goyal, Sharad ⁱ   Horst, Kathleen C ^e   Moran, Meena S ^j   MacDonald, Shannon M ^g   Haffty, Bruce G ⁱ  

^a MAYO CLINIC   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Summitt Medical Center   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

ⁱ ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k AMERICAN COLLEGE OF RADIOLOGY   (United States)

more..

Author keywords

Appropriateness criteria; Breast cancer; Local regional recurrence; Relapse; Salvage therapy

Indexed keywords

BRCA1 PROTEIN; HORMONE; TAMOXIFEN; TRASTUZUMAB; ANTINEOPLASTIC AGENT; TUMOR MARKER;

ADJUVANT THERAPY; BRACHYTHERAPY; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; HORMONAL THERAPY; HUMAN; LOCAL REGIONAL RECURRENCE; LYMPH NODE DISSECTION; MASTECTOMY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; RECURRENCE RISK; REVIEW; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CHEMISTRY; CLINICAL TRIAL (TOPIC); EVIDENCE BASED MEDICINE; FEMALE; METHODOLOGY; PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; SALVAGE THERAPY; SEGMENTAL MASTECTOMY; SURVIVAL; TREATMENT FAILURE; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL;

EID: 84860659670     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3182439084     Document Type: Review

References (43)

1. Abner AL, Recht A, Eberlein T, et al. Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1993;11:44-48. (Pubitemid 23059973)
2. Moran MS, Haffty BG. Local-regional breast cancer recurrence: Prognostic groups based on patterns of failure. Breast J. 2002;8:81-87. (Pubitemid 34233585)
3. van Tienhoven G, Voogd AC, Peterse JL, et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer. 1999; 35:32-38. (Pubitemid 29079488)
4. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087-2106. (Pubitemid 41797643)
5. Nielsen HM, Overgaard M, Grau C, et al. Loco-regional recurrence after mastectomy in high-risk breast cancer-risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. Radiother Oncol. 2006;79:147-155. (Pubitemid 43867814)
6. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116-126. (Pubitemid 40277091)
7. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 2007;82:247-253. (Pubitemid 46350797)
8. Anderson SJ, Wapnir I, Dignam JJ, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27:2466-2473.
9. Arriagada R, Le MG, Contesso G, et al. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol. 2002;13:1404-1413.
10. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007;25:3259-3265. (Pubitemid 47325610)
11. de Bock GH, van der Hage JA, Putter H, et al. Isolated locoregional recurrence of breast cancer is more common in young patients and following breast conserving therapy: Long-term results of European Organisation for Research and Treatment of Cancer studies. Eur J Cancer. 2006;42:351-356. (Pubitemid 43132890)
12. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J Clin Oncol. 2001;19: 1688-1697. (Pubitemid 32230869)
13. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project nodepositive adjuvant breast cancer trials. J Clin Oncol. 2006;24: 2028-2037. (Pubitemid 46622111)
14. Freedman GM, Hanlon AL, Fowble BL, et al. Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. J Clin Oncol. 2002;20:4015-4021.
15. Kreike B, Hart AA, van de Velde T, et al. Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up. Int J Radiat Oncol Biol Phys. 2008;71: 1014-1021.
16. Voduc KD, Cheang MC, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol. 2010;28:1684-1691.
17. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241. (Pubitemid 35176242)
18. Potter R, Gnant M, Kwasny W, et al. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys. 2007;68:334-340. (Pubitemid 46694171)
19. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol. 2001;12:997-1003. (Pubitemid 32725776)
20. Livi L, Paiar F, Saieva C, et al. Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment. Radiother Oncol. 2007;82:287-293. (Pubitemid 46350791)
21. Antonucci JV, Wallace M, Goldstein NS, et al. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: A matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys. 2009; 74:447-452.
22. Arthur DW, Winter K, Kuske RR, et al. A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2008;72:467-473.
23. Nelson JC, Beitsch PD, Vicini FA, et al. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Am J Surg. 2009;198:83-91.
24. Polgar C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694-702. (Pubitemid 47418409)
25. Chen AM, Meric-Bernstam F, Hunt KK, et al. Breast conservation after neoadjuvant chemotherapy. Cancer. 2005;103:689-695.
26. Peintinger F, Symmans WF, Gonzalez-Angulo AM, et al. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer. 2006;107:1248-1254. (Pubitemid 44452773)
27. Carlson RW, Anderson BO, Burstein HJ, et al. Breast cancer. J Natl Compr Canc Netw. 2005;3:238-289.
28. Harris EE, Hwang WT, Seyednejad F, et al. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy. Cancer. 2003;98:2144-2151. (Pubitemid 37392417)
29. Port ER, Garcia-Etienne CA, Park J, et al. Reoperative sentinel lymph node biopsy: A new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol. 2007; 14:2209-2214. (Pubitemid 47174900)
30. Wapnir IL, Aebi S, Gelber S, et al. Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer. Ann Surg Oncol. 2008;15: 3227-3231.
31. Nishimura S, Takahashi K, Akiyama F, et al. Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: New primary cancer allows a good prognosis. Breast Cancer. 2005;12:112-117.
32. Smith TE, Lee D, Turner BC, et al. True recurrence vs. new primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys. 2000;48:1281-1289.
33. Graeser MK, Engel C, Rhiem K, et al. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2009;27:5887-5892.
34. Solin LJ, Fourquet A, Vicini FA, et al. Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. Eur J Cancer. 2005;41:1715-1723. (Pubitemid 41132631)
35. Buchanan CL, Dorn PL, Fey J, et al. Locoregional recurrence after mastectomy: Incidence and outcomes. J Am Coll Surg. 2006;203:469-474. (Pubitemid 44416252)
36. Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol. 2004;22:4247-4254. (Pubitemid 41185145)
37. Kyndi M, Sorensen FB, Knudsen H, et al. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26:1419-1426.
38. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;365:1687-1717.
39. Halverson KJ, Perez CA, Kuske RR, et al. Locoregional recurrence of breast cancer: A retrospective comparison of irradiation alone versus irradiation and systemic therapy. Am J Clin Oncol. 1992;15:93-101.
40. Haylock BJ, Coppin CM, Jackson J, et al. Locoregional first recurrence after mastectomy: Prospective cohort studies with and without immediate chemotherapy. Int J Radiat Oncol Biol Phys. 2000;46:355-362. (Pubitemid 30067785)
41. Schmoor C, Sauerbrei W, Bastert G, et al. Role of isolated locoregional recurrence of breast cancer: Results of four prospective studies. J Clin Oncol. 2000;18:1696-1708. (Pubitemid 30220548)
42. Haffty BG, Hauser A, Choi DH, et al. Molecular markers for prognosis after isolated postmastectomy chest wall recurrence. Cancer. 2004;100:252-263. (Pubitemid 38063632)
43. Willner J, Kiricuta IC, Kolbl O. Locoregional recurrence of breast cancer following mastectomy: Always a fatal event? Results of univariate and multivariate analysis. Int J Radiat Oncol Biol Phys. 1997;37:853-863 (Pubitemid 27181319)